Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 17, 2020, UnitedHealth Group Incorporated (the "Company") filed a Form 8-K announcing Sir Andrew Witty, President of the Company and Chief Executive Officer of Optum, would be on an unpaid leave of absence from the Company to co-lead a global effort of the World Health Organization, in partnership with key stakeholders, to accelerate the development of a COVID-19 vaccine.

On December 2, 2020, the Company issued a press release announcing that Witty will return to his positions as the President of the Company and Chief Executive Officer of Optum, effective December 1, 2020. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.



Information regarding Witty's business experience and other information required
by this Item 5.02 can be found in the Company's 2019 10-K and 2020 Proxy
Statement.


Item 9.01.  Financial Statements and Exhibits.
Exhibit     Description
  99.1        Press Release dated December 2, 2020
104         Cover Page Interactive Data File (formatted as Inline XBRL).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses